Why weight loss on Mounjaro can feel slower than expected

What SURMOUNT-1 actually shows about the timeline

The SURMOUNT-1 trial followed 2,539 adults with obesity over 72 weeks. The headline figures (roughly 20% average weight loss at 15mg) get quoted constantly, but the weight-loss curves in the published paper are equally telling. Loss was not front-loaded. Participants continued to lose weight steadily through weeks 36, 48 and beyond at therapeutic doses. The first month, when most people start at 2.5mg, produced the smallest absolute losses: that dose is a tolerability measure, not a therapeutic one. The body needs time to adjust to each step of the titration schedule before the appetite-suppressing and metabolic effects fully establish themselves.

This matters because many people benchmark their progress against week-two social media posts rather than the actual trial timeline. A slower start does not predict a poor outcome. The NHS medicines page for tirzepatide notes that it can take several weeks for the full effect to become apparent, particularly during dose escalation.

If you want a detailed week-by-week picture of what to expect early on, what happens in week one on Mounjaro is covered separately.

Four reasons progress can plateau or slow on Mounjaro

There is no single explanation for a slow patch, but the evidence points to a predictable set of contributors. First, dose level matters considerably: participants at 5mg in SURMOUNT-1 lost less than those who reached 10 or 15mg, so someone partway through titration will naturally see less on the scales than the trial average suggests. Second, metabolic adaptation (the body reducing energy expenditure in response to weight loss) is a well-documented biological phenomenon that slows progress regardless of the medicine involved. Third, dietary composition can blunt results; adequate protein intake and reduced ultra-processed food intake are consistently associated with better outcomes alongside GLP-1 treatment. Fourth, water retention, hormonal fluctuations and bowel habit changes can mask fat loss on any given week, making the scales an unreliable short-term judge.

A prescriber can help distinguish a true plateau from a phase of slower visible progress. The page on very slow weight loss on Mounjaro covers what to do if movement has stalled for an extended period.

When slow is still normal, and when to raise it with your prescriber

NICE's appraisal of tirzepatide (TA1026) includes a review trigger: if someone has not lost at least 5% of their starting weight after six months at the highest tolerated dose, continuing treatment should be reconsidered. That benchmark is deliberately set at six months on the maintenance dose, not six weeks into the starter dose. Raising concerns before then is reasonable and welcomed by good prescribers, but it should prompt a conversation rather than abandonment of treatment.

Practical reasons to contact your prescriber sooner include: side effects that are preventing you from eating enough protein or staying hydrated; a dose that has not been increased according to the expected schedule; significant new life stressors affecting sleep or activity levels. None of these are failures. They are clinical variables a prescriber needs to know about. If the scales have not budged despite doing everything right, the guidance on why some people see no weight loss on Mounjaro explains the most common clinical reasons and what can be done. It is also worth knowing that week three with no weight loss on Mounjaro is a pattern that comes up regularly and is usually explainable within the normal titration process. You can explore the broader evidence on how Mounjaro drives weight loss or read about how long the medicine typically takes to produce noticeable results on the timeline page.

For anyone curious about the process at nume, your consultation is reviewed by a real prescriber, a GPhC-registered Independent Prescriber reads your answers and makes a clinical decision. If approved, treatment is dispatched the same day (for orders placed before noon, Monday to Friday), and DPD delivers it to your door the next working day in plain, unbranded packaging. That includes the KwikPen itself, which arrives cold-packed and ready to go straight in the fridge.

For context on what treatment costs and what is included in that price, the treatment overview page sets it out plainly, one transparent price covering consultation, prescription, delivery and aftercare, with no subscription.